With the Nasdaq at record highs, these are the benchmark’s most beloved stocks that are expected to rally
The tech-heavy index closed at its first record high in more than two years on Thursday. Source link
Read MoreThe tech-heavy index closed at its first record high in more than two years on Thursday. Source link
Read MoreAs the bull market slows, these cheap stocks could emerge as big winners. Source link
Read MoreAnti-obesity drugmakers Novo Nordisk and Eli Lilly have a huge lead on their competition, but it's coming. Source link
Read MoreOver the last 12 months, just 11 stocks made up half of the gains that powered the pan-European Stoxx 600
Read MoreNovo Nordisk and Eli Lilly have given positive supply updates, aiming to reassure investors that they can continue to capitalize
Read MoreAware uses AI to analyze companies' employee messages across Slack, Microsoft Teams, Zoom and other communications services. Source link
Read MoreThe JPMorgan Healthcare Conference was likely just the beginning of another year of heightened interest and investments in ADC cancer
Read MoreMany biotech stocks struggled in 2023 despite a robust year for U.S. drug approvals. A look at what 2024 might
Read MoreNext year could set the precedent for the Inflation Reduction Act's controversial talks, which could affect dozens of medications by
Read More